Literature DB >> 15580463

[Vertebrobasilar ischemia as a complication of temporal arteritis. Results of a prospective, clinical, ultrasonographic study].

K Pfadenhauer1, M Esser, H Weber, K D Wölfle.   

Abstract

BACKGROUND: Cerebral symptoms in temporal arteritis (TA) may occur if large arteries are affected. To avoid progression of the disease, the immediate administration of adequate doses of steroids is mandatory.
PURPOSE: The prevalence and severity of vertebrobasilar ischemia (VBI) and its relation to structural abnormalities of the vertebral arteries were studied.
METHODS: Clinical and ultrasound data were analyzed in a hospital-based group of 91 patients who received the diagnosis of TA following standard criteria.
RESULTS: In contrast to the occurrence of neuro-ophthalmological complications (27.5%), the rate of VBI was low (4.4%). TIA occurred in three cases and mild stroke in one. Ultrasound demonstrated severe occlusive disease of the extradural parts of the vertebrobasilar arteries consisting of hypoechogenic, concentric, mural thickening. The same was found in the superficial temporal arteries.
CONCLUSIONS: In elderly patients presenting with VBI, TA affecting the vertebral arteries should be considered. In experienced hands, ultrasonography allows the atraumatic preliminary diagnosis of TA.

Entities:  

Mesh:

Year:  2005        PMID: 15580463     DOI: 10.1007/s00115-004-1853-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

1.  Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection.

Authors:  Matthias Reinhard; Dieter Schmidt; Martin Schumacher; Andreas Hetzel
Journal:  J Neurol       Date:  2003-08       Impact factor: 4.849

2.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

3.  Ophthalmoplegia in cranial arteritis.

Authors:  M E Barricks; D B Traviesa; J S Glaser; I S Levy
Journal:  Brain       Date:  1977-06       Impact factor: 13.501

4.  Therapeutic effects of acetylsalicylic acid in giant cell arteritis.

Authors:  Cornelia M Weyand; Markus Kaiser; Hongyu Yang; Brian Younge; Jörg J Goronzy
Journal:  Arthritis Rheum       Date:  2002-02

5.  Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement.

Authors:  I M Wilkinson; R W Russell
Journal:  Arch Neurol       Date:  1972-11

6.  Neurologic disease in biopsy-proven giant cell (temporal) arteritis.

Authors:  R J Caselli; G G Hunder; J P Whisnant
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

7.  Giant cell arteritis. Clinical features and involvement of different organs.

Authors:  B E Malmvall; B A Bengtsson
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

8.  Ultrasound findings in spontaneous extracranial vertebral artery dissection.

Authors:  M Sturzenegger; H P Mattle; A Rivoir; F Rihs; C Schmid
Journal:  Stroke       Date:  1993-12       Impact factor: 7.914

9.  Systemic giant cell arteritis and cerebellar infarction.

Authors:  C A Mclean; M F Gonzales; J P Dowling
Journal:  Stroke       Date:  1993-06       Impact factor: 7.914

10.  [Present state of ultrasonographic diagnosis of temporal arteritis. Results of a prospective study].

Authors:  K Pfadenhauer; H Weber
Journal:  Nervenarzt       Date:  2003-06-14       Impact factor: 1.214

View more
  2 in total

Review 1.  [Imaging procedures for giant cell arteritis (Horton's disease)].

Authors:  T A Bley; I Brink; M Reinhard
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

2.  3-T MRI detects inflammatory stenosis of the vertebral artery in giant cell arteritis.

Authors:  J Geiger; M Uhl; H H Peter; M Langer; T A Bley
Journal:  Clin Rheumatol       Date:  2008-01-03       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.